[CLSTR]
< Back to situations

We’ll email you as it develops, and you can follow the whole thread from day one.

[SITUATION] · [ACTIVE]

5 clusters · 12 sources · 15 days · First seen · Last updated

Categories: BUSINESS

Market forecast reports expand across sectors

Entities: Companion Diagnostics market · Data Bridge Market Research · F. Hoffmann‑La Roche Ltd. · Anatomic Pathology market · Bio‑Rad Laboratories, Inc.

Overview

In late July 2026 a wave of market‑research publications projected robust growth for a wide range of industries, from crop‑insurance and genomics to elevators, infusion pumps, semiconductor metrology and Indonesia’s mobile‑services market. The forecasts cited climate‑related risks, AI, IoT and 5G adoption as primary drivers. Around the same time, Japanese distributor SEMABIZ announced two health‑care‑focused reports: a global biomarkers market outlook to 2031 and a pulse‑lavage market projection to 2033. The biomarkers report projected a rise from US$67.95 billion in 2026 to US$112.1 billion by 2031, driven by AI‑enabled digital pathology and precision‑medicine uptake. The pulse‑lavage study forecast the market to more than double by 2033, citing growing demand for infection‑control solutions in orthopedic, trauma and cardiovascular surgery. On 3 August 2026, Fortune Business Insights released broader forecasts for the global biomarkers market (projected US$244 billion by 2034) and the proteomics market (US$67.6 billion by 2031). Both reports highlighted extensive product launches, strategic partnerships and M&A activity among leading life‑science firms, reinforcing the trend of increasingly detailed, technology‑driven market analyses across commercial and medical sectors. Data Bridge Market Research added forecasts for the Spare Parts Management market, valuing it at US$1.20 billion in 2025 and projecting US$2.62 billion by 2033 (CAGR 10.3%). It also projected the functional genomics market to grow from US$7.28 billion in 2025 to US$16.89 billion by 2033 (CAGR 11.1%). A further report released on 6 August 2026 projected the global Anatomic Pathology market to rise from US$8.9 billion in 2026 to US$14.5 billion by 2031 (CAGR 10.2%) and the Companion Diagnostics market to grow from US$6.31 billion to US$11.57 billion over the same period (CAGR 12.9%). Growth is attributed to precision‑medicine adoption, targeted oncology therapies and expanding use of PCR and next‑generation sequencing, extending the pattern of detailed, technology‑driven market outlooks in the life‑science sector.

Timeline

  1. 2 days ago

    [BUSINESS] 2 sources
    Global Anatomic Pathology and Companion Diagnostics Markets Projected to Reach $14.5B and $11.6B by 2031

    Anatomic pathology market to hit $14.5 bn by 2031 (CAGR 10.2%) and companion diagnostics to reach $11.6 bn (CAGR 12.9%), with North America leading both sectors.

  2. 5 days ago

    [BUSINESS] 2 sources
    Data Bridge Market Research projects growth in global spare parts and functional genomics markets

    Data Bridge Market Research forecasts the global spare parts management market to reach $2.62 bn by 2033 (CAGR 10.3%) and the functional genomics market to $16.89 bn (CAGR 11.1%).

  3. 5 days ago

    [BUSINESS] 2 sources
    Global Biomarkers and Proteomics Markets Forecast Strong Growth Through 2034

    Biomarkers market could hit $244 bn by 2034 (CAGR 12.1%) and proteomics $67.6 bn by 2031 (CAGR 11.1%), driven by precision‑medicine demand and major life‑science firms.

  4. 16 days ago

    [BUSINESS] 2 sources
    SEMABIZ launches global biomarker and pulse‑lavage market forecast reports

    SEMABIZ rolled out two new market‑research reports: a biomarker market forecast (US$68 bn → $112 bn, 10.5% CAGR) and a pulse‑lavage market outlook (US$56 m → $104 m, 8.2% CAGR), highlighting AI‑driven precision

  5. 16 days ago

    [BUSINESS] 7 sources
    Global Market Forecasts Show Strong Growth Across Diverse Sectors

    Market reports project strong growth: crop‑insurance to $106 bn by 2035, genome sequencing to $1.06 tn by 2033, genome‑editing to $18 bn by 2030, elevators to $148 bn by 2032, infusion pumps to $28 bn by 2030,

Sources

aijourn.com · bklynlifenews.com · californianewswire.com · dreamnews.jp · evere.co · globaldata.com · marketsandmarketsblog.com · reportsnreports.com · rock967online.com · siliconsemiconductor.net · socialbee.com · youthsoccercup.com

This summary has been updated 2 times: see revision history